The EU Committee on Proprietary Medicinal Products to which the UK had recommended a policy of recall if a plasma pool was found to have been made in part from a donation from someone who had subsequently developed vCJD, agreed there should be a recall and SEAC agreed the surveillance until would set up a procedure to report cases.